Ensysce Biosciences, Inc. (ENSC)
0.4803
+0.01
(+1.54%)
USD |
NASDAQ |
Sep 09, 10:55
Ensysce Biosciences Shareholders Equity (Quarterly) : -0.7817M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.7817M |
| March 31, 2026 | -0.34M |
| December 31, 2025 | 3.214M |
| September 30, 2025 | 1.203M |
| June 30, 2025 | 3.389M |
| March 31, 2025 | 3.049M |
| December 31, 2024 | 3.708M |
| September 30, 2024 | 6.908M |
| June 30, 2024 | 1.808M |
| March 31, 2024 | 3.749M |
| December 31, 2023 | -0.3229M |
| September 30, 2023 | 1.485M |
| June 30, 2023 | 4.119M |
| March 31, 2023 | 0.1667M |
| December 31, 2022 | -3.714M |
| September 30, 2022 | -6.094M |
| June 30, 2022 | -0.4916M |
| March 31, 2022 | 1.391M |
| Date | Value |
|---|---|
| December 31, 2021 | -7.878M |
| September 30, 2021 | -0.1057M |
| June 30, 2021 | 5.411M |
| March 31, 2021 | 1.894M |
| December 31, 2020 | -6.441M |
| September 30, 2020 | 5.271M |
| June 30, 2020 | 5.052M |
| March 31, 2020 | 9.541M |
| December 31, 2019 | 186.17M |
| September 30, 2019 | 199.08M |
| June 30, 2019 | 198.59M |
| March 31, 2019 | 198.17M |
| December 31, 2018 | 197.39M |
| September 30, 2018 | 196.67M |
| June 30, 2018 | 196.09M |
| March 31, 2018 | 195.68M |
| December 31, 2017 | 195.27M |
| September 30, 2017 | 0.02M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 465.53M |
| Oncolytics Biotech, Inc. | -6.167M |
| Sangamo Therapeutics, Inc. | -18.96M |
| Sarepta Therapeutics, Inc. | 1.528B |
| Anixa Biosciences, Inc. | 14.48M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.957M |
| Total Liabilities (Quarterly) | 4.068M |
| Debt to Equity Ratio | -0.2518 |
| Current Ratio | 0.6031 |
| Net Debt Paydown Yield | 0.18% |